ID CP17A_PAPHU Reviewed; 508 AA. AC Q9GLD2; Q95M62; DT 28-NOV-2003, integrated into UniProtKB/Swiss-Prot. DT 01-MAR-2001, sequence version 1. DT 27-MAR-2024, entry version 97. DE RecName: Full=Steroid 17-alpha-hydroxylase/17,20 lyase; DE EC=1.14.14.19 {ECO:0000269|PubMed:12423360}; DE EC=1.14.14.32 {ECO:0000269|PubMed:12423360}; DE AltName: Full=CYPXVII; DE AltName: Full=Cytochrome P450 17A1; DE AltName: Full=Cytochrome P450-C17; DE Short=Cytochrome P450c17; DE AltName: Full=Steroid 17-alpha-monooxygenase; GN Name=CYP17A1; Synonyms=CYP17; OS Papio hamadryas ursinus (Chacma baboon). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; OC Cercopithecidae; Cercopithecinae; Papio. OX NCBI_TaxID=36229; RN [1] RP NUCLEOTIDE SEQUENCE. RC TISSUE=Adrenal gland; RA Swart A.C., Kolar N.W., Swart P.; RT "Cloning and expression of baboon cytochrome P-450 17-alpha RT hydroxylase/c17-20 lyase."; RL Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=12423360; DOI=10.1046/j.1432-1033.2002.03268.x; RA Swart A.C., Kolar N.W., Lombard N., Mason J.I., Swart P.; RT "Baboon cytochrome P450 17alpha-hydroxylase/17,20-lyase (CYP17)."; RL Eur. J. Biochem. 269:5608-5616(2002). CC -!- FUNCTION: A cytochrome P450 monooxygenase involved in corticoid and CC androgen biosynthesis. Catalyzes 17-alpha hydroxylation of C21 CC steroids, which is common for both pathways (PubMed:12423360). A second CC oxidative step, required only for androgen synthesis, involves an acyl- CC carbon cleavage. Hydroxylates pregnenolone to form 17-alpha CC pregnenolone, followed by the cleavage of the C17-C20 bond to form CC dehydroepiandrosterone (DHEA) (PubMed:12423360). Has 17-alpha CC hydroxylase activity toward progesterone (PubMed:12423360). The 17- CC alpha hydroxy intermediates, as part of adrenal glucocorticoids CC biosynthesis pathway, are precursors of cortisol. Mechanistically, uses CC molecular oxygen inserting one oxygen atom into a substrate, and CC reducing the second into a water molecule, with two electrons provided CC by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein CC reductase) (By similarity). {ECO:0000250|UniProtKB:P05093, CC ECO:0000269|PubMed:12423360}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a C21-steroid + O2 + reduced [NADPH--hemoprotein reductase] = CC a 17alpha-hydroxy-C21-steroid + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:65760, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210, ChEBI:CHEBI:61313, ChEBI:CHEBI:138141; CC EC=1.14.14.19; Evidence={ECO:0000250|UniProtKB:P05093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65761; CC Evidence={ECO:0000250|UniProtKB:P05093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=O2 + progesterone + reduced [NADPH--hemoprotein reductase] = CC 17alpha-hydroxyprogesterone + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:46308, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:17026, CC ChEBI:CHEBI:17252, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; CC EC=1.14.14.19; Evidence={ECO:0000250|UniProtKB:P05093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46309; CC Evidence={ECO:0000250|UniProtKB:P05093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=O2 + pregnenolone + reduced [NADPH--hemoprotein reductase] = CC 17alpha-hydroxypregnenolone + H(+) + H2O + oxidized CC [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:50236, Rhea:RHEA- CC COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16581, CC ChEBI:CHEBI:28750, ChEBI:CHEBI:57618, ChEBI:CHEBI:58210; CC EC=1.14.14.19; Evidence={ECO:0000250|UniProtKB:P05093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50237; CC Evidence={ECO:0000250|UniProtKB:P05093}; CC -!- CATALYTIC ACTIVITY: CC Reaction=17alpha-hydroxypregnenolone + O2 + reduced [NADPH--hemoprotein CC reductase] = 3beta-hydroxyandrost-5-en-17-one + acetate + 2 H(+) + CC H2O + oxidized [NADPH--hemoprotein reductase]; Xref=Rhea:RHEA:50244, CC Rhea:RHEA-COMP:11964, Rhea:RHEA-COMP:11965, ChEBI:CHEBI:15377, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:28689, CC ChEBI:CHEBI:28750, ChEBI:CHEBI:30089, ChEBI:CHEBI:57618, CC ChEBI:CHEBI:58210; EC=1.14.14.32; CC Evidence={ECO:0000250|UniProtKB:P05093}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50245; CC Evidence={ECO:0000250|UniProtKB:P05093}; CC -!- COFACTOR: CC Name=heme; Xref=ChEBI:CHEBI:30413; CC Evidence={ECO:0000250|UniProtKB:P05093}; CC -!- ACTIVITY REGULATION: Regulated predominantly by intracellular cAMP CC levels. The 17,20-lyase activity is stimulated by cytochrome b5, which CC acts as an allosteric effector increasing the Vmax of the lyase CC activity. {ECO:0000250|UniProtKB:P05093}. CC -!- PATHWAY: Steroid hormone biosynthesis. {ECO:0000250|UniProtKB:P05093}. CC -!- PATHWAY: Steroid biosynthesis; glucocorticoid biosynthesis. CC {ECO:0000250|UniProtKB:P05093}. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000250|UniProtKB:P05093}. Microsome membrane CC {ECO:0000250|UniProtKB:P05093}. CC -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF297650; AAG10599.1; -; mRNA. DR EMBL; AY034635; AAK57726.1; -; Genomic_DNA. DR AlphaFoldDB; Q9GLD2; -. DR SMR; Q9GLD2; -. DR BRENDA; 1.14.14.19; 4524. DR UniPathway; UPA00788; -. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0047442; F:17-alpha-hydroxyprogesterone aldolase activity; ISS:UniProtKB. DR GO; GO:0020037; F:heme binding; ISS:UniProtKB. DR GO; GO:0005506; F:iron ion binding; IEA:InterPro. DR GO; GO:0004508; F:steroid 17-alpha-monooxygenase activity; ISS:UniProtKB. DR GO; GO:0006704; P:glucocorticoid biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0042446; P:hormone biosynthetic process; ISS:UniProtKB. DR GO; GO:0042448; P:progesterone metabolic process; ISS:UniProtKB. DR GO; GO:0008202; P:steroid metabolic process; ISS:UniProtKB. DR CDD; cd20673; CYP17A1; 1. DR Gene3D; 1.10.630.10; Cytochrome P450; 1. DR InterPro; IPR001128; Cyt_P450. DR InterPro; IPR017972; Cyt_P450_CS. DR InterPro; IPR002401; Cyt_P450_E_grp-I. DR InterPro; IPR036396; Cyt_P450_sf. DR PANTHER; PTHR24289; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; 1. DR PANTHER; PTHR24289:SF13; STEROID 17-ALPHA-HYDROXYLASE_17,20 LYASE; 1. DR Pfam; PF00067; p450; 1. DR PRINTS; PR00463; EP450I. DR PRINTS; PR00385; P450. DR SUPFAM; SSF48264; Cytochrome P450; 1. DR PROSITE; PS00086; CYTOCHROME_P450; 1. PE 1: Evidence at protein level; KW Endoplasmic reticulum; Heme; Iron; Lipid metabolism; Lyase; Membrane; KW Metal-binding; Microsome; Monooxygenase; Oxidoreductase; Steroidogenesis. FT CHAIN 1..508 FT /note="Steroid 17-alpha-hydroxylase/17,20 lyase" FT /id="PRO_0000051938" FT BINDING 202 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:P05093" FT BINDING 442 FT /ligand="heme" FT /ligand_id="ChEBI:CHEBI:30413" FT /ligand_part="Fe" FT /ligand_part_id="ChEBI:CHEBI:18248" FT /note="axial binding residue" FT /evidence="ECO:0000250" FT CONFLICT 331 FT /note="G -> E (in Ref. 2; AAK57726)" FT /evidence="ECO:0000305" FT CONFLICT 396 FT /note="L -> R (in Ref. 2; AAK57726)" FT /evidence="ECO:0000305" SQ SEQUENCE 508 AA; 57566 MW; 40DF6068D66BAA80 CRC64; MWELVALLLL TLAYLFWPKR RCPGAKYPKS LLSLPLVGSL PFLPRHGHMH NNFFKLQKKY GPIYSVRMGT KTTVIVGHHQ LAKEVLIKKG KDFSGRPQVT TLDILSNNRK GIAFADYGAH WQLHRRLAMA TFALFKDGDQ KLEKIICQEI STLCDMLATH NGQTIDISFP VFVAITNVIS LICFNISYKN GDPELKIVHN YNEGIIDSLG KESLVDLFPW LKVFPNKTLE KLKRHVKTRN DLLTKIFENY KEKFRSDSIT NMLDVLMQAK MNSDNGNAGP DQDSELLSDN HILTTIGDIF GAGVETTTSV VKWIVAFLLH NPQVKKKLYE GIDQNVGFSR TPTISDRNRL LLLEATIREV LRIRPVAPML IPHKANVDSS IGEFAVDKGT HVIINLWALH HNEKEWHQPD QFMPERFLNP AGTQLISPSL SYLPFGAGPR SCIGEILARQ ELFLIMAWLL QRFDLEVPDD GQLPSLEGNP KVVFLIDSFK VKIKVRQAWR EAQAEGST //